A detailed history of Gamma Investing LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Gamma Investing LLC holds 4,204 shares of ALKS stock, worth $123,135. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,204
Previous 2,287 83.82%
Holding current value
$123,135
Previous $55.1 Million 113.49%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$23.01 - $28.55 $44,110 - $54,730
1,917 Added 83.82%
4,204 $118 Million
Q2 2024

Jul 02, 2024

BUY
$23.21 - $27.24 $16,316 - $19,149
703 Added 44.38%
2,287 $55.1 Million
Q1 2024

Apr 05, 2024

BUY
$26.4 - $32.56 $7,392 - $9,116
280 Added 21.47%
1,584 $42.9 Million
Q4 2023

Feb 01, 2024

BUY
$23.37 - $28.68 $30,474 - $37,398
1,304 New
1,304 $35.3 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.81B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.